Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 158,687 shares at $155.54 ($24.8M) on 2023-04-05, disclosed to the SEC on 2023-04-07.
Scheduled sale ($24.8M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.74 | 6,666 | $1.0M | 4.1% |
| 2 | $152.74 | 6,666 | $1.0M | 4.1% |
| 3 | $153.66 | 2,934 | $451K | 1.8% |
| 4 | $153.66 | 2,934 | $451K | 1.8% |
| 5 | $155.01 | 22,533 | $3.5M | 14.1% |
| 6 | $155.01 | 22,533 |
| $3.5M |
| 14.1% |
| 7 | $155.54 | 7,754 | $1.2M | 4.9% |
| 8 | $155.54 | 7,754 | $1.2M | 4.9% |
| 9 | $156.50 | 113 | $18K | 0.1% |
| 10 | $154.79 | 2,739 | $424K | 1.7% |
| 11 | $154.79 | 2,739 | $424K | 1.7% |
| 12 | $155.58 | 7,602 | $1.2M | 4.8% |
| 13 | $155.58 | 7,602 | $1.2M | 4.8% |
| 14 | $157.00 | 1,200 | $188K | 0.8% |
| 15 | $158.19 | 25,343 | $4.0M | 16.2% |
| 16 | $158.19 | 25,343 | $4.0M | 16.2% |
| 17 | $158.81 | 3,116 | $495K | 2.0% |
| 18 | $158.81 | 3,116 | $495K | 2.0% |
| Total | $156.05 avg | 158,687 | $24.8M | 100% |
| Filing → |
| MRNA | SELL | 2024-02-16 | $4.7M | — | Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |